MedPath

Methodological Study of the Effect of a Lotion Containing Nature Based Microbial Extract on Atopic Skin

Not Applicable
Completed
Conditions
Atopic Dermatitis
Interventions
Other: Biodiversity intervention by inactivated microbial extract
Other: Placebo intervention by colored lotion
Registration Number
NCT06499766
Lead Sponsor
Uute Scientific Oy
Brief Summary

The purpose of the study is to test the selected methods and to explore the effect of nature-based exposure on immunological biomarkers and the condition of atopic skin. Overall purpose is to test the safety and feasibility of a new nature-exposure method on atopic skin: regular use of lotion containing inactivated microbial extract that mimics Finnish forest microbial biodiversity.

Detailed Description

According of hygiene and biodiversity hypotheses, regular contact to nature biodiversity is beneficial for human health. Without the contact, there is risk for immune system malfunction and related diseases like atopy, allergies and inflamed bowel diseases. Regular contact to natural biodiversity, including environmental microbes, add immunological tolerance and train immune system to separate dangerous external stimuli from non-dangerous ones.

This study aim at testing if it is safe to use microbial extract in lotion on daily basis on atopic skin. Study participants are adults and they have atopic dermatitis diagnosis. Participants use the lotion with microbial extract on other arm and placebo lotion (same lotion but microbial extract is replaced with safe coloring ingredient) on the other arm two times per day for 28 days. Atopy medicines are not used on the study period and 14 days before the study. Also, other moisturizers than test lotions are not used on test areas during the study.

Study is placebo controlled, randomized and double-blinded.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Age between 18 and 65
  • Legally competence
  • Fullfills Hanifin & Rajka criteria for atopic dermatitis
  • Commitment to the study
Exclusion Criteria
  • Regular contact to farming environment
  • Cancer or on going cancer treatments
  • Use of immunosuppressive medicines
  • Photo therapy, solarium or vacation abroad during the study
  • Too severe eczema (not possible to keep pause from atopy medicines)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Nature-based exposure by biodiversity component in lotion.Biodiversity intervention by inactivated microbial extractBiodiversity component is highly diverse microbial extract mimicking Finnish forest soil biodiversity. Component is added to the common moisturizer on the Finnish market.
Placebo by coloring component in lotion.Placebo intervention by colored lotionColoring ingredient is safe, biochemically non-active component which purpose is to make the placebo lotion looking same as the biodiversity lotion in other arm. Component is added to the common moisturizer on the Finnish market (same as in the other arm).
Primary Outcome Measures
NameTimeMethod
Transepidermal water loss (TEWL)0, 14 and 28 days

TEWL measurement from each test area (arms)

Secondary Outcome Measures
NameTimeMethod
SCORAD (SCORing Atopic Dermatitis)0 and 28 days

Scoring of atopic dermatitis (whole body) by dermatologist. Scale 0-103.

Skin erythema index0, 14 and 28 days

Erythema index measurement from each test area (arms)

Pro-inflammatory cytokines on skin0 and 28 days

Tape strip samples from both arms and cytokine analysis from the samples.

Local scoring of eczema on arms0 and 28 days

Local scoring of eczema only on arms (each arm separately) by dermatologist. Scale 0-18.

Self evaluation of eczema symptoms and effect of the lotion0, 7, 14, 21 and 28 days

Filling of self questionnaire every week

Trial Locations

Locations (1)

Uute Scientific Oy

🇫🇮

Helsinki, Finland

© Copyright 2025. All Rights Reserved by MedPath